Current Edition

booster

FDA ready to bless mixing and matching of COVID-19 vaccines as boosters

Data from a National Institutes of Health (NIH) study on booster shots have convinced the FDA to allow Americans to use a different COVID-19 vaccine …

Continue Reading →
clinical

NIH-funded researchers present preliminary clinical trial results suggesting aggressive blood pressure control may lower risk of cognitive impairment

What Preliminary findings from a large clinical trial, the Systolic Blood Pressure Intervention Trial (SPRINT) Memory and Cognition IN Decreased Hypertension (SPRINT MIND) study will …

Continue Reading →
clinial

NIH delays controversial clinical trials policy for some studies

Basic brain and behavioral researchers will get more than a year to comply with a new U.S. policy that will treat many of their studies …

Continue Reading →
clinical

NIH Opening First Mesothelioma Clinical Trial for Lynparza

The National Institutes of Health (NIH) in Bethesda, Maryland, is opening the first mesothelioma clinical trial involving the immunotherapy drug Lynparza (olaparib), a protein inhibitor …

Continue Reading →